Skip to main content
. 2021 May 28;10(6):866. doi: 10.3390/antiox10060866

Table 3.

Changes in oxidative stress and antioxidant substances in serum (S) and urine (U).

Unit Trial Pre Post 1h 2h Trial Time Interaction
d-ROMs-S U-CARR REH 237.77 ± 10.67 234.38 ± 10.36 237.37 ± 10.64 233.00 ± 11.37 0.138 0.327 0.567
CON 230.00 ± 9.50 218.87 ± 9.87 224.70 ± 10.90 227.84 ± 10.73
BAP-S mmol/L REH 2.28 ± 0.05 2.32 ± 0.05 2.31 ± 0.07 2.36 ± 0.06 0.218 0.343 0.474
CON 2.20 ± 0.05 2.26 ± 0.04 2.32 ± 0.06 2.23 ± 0.03
Uric Acid-S mg/dL *** *** ** 0.427 <0.001 0.602
REH 5.43 ± 0.35 5.11 ± 0.34 7.01 ± 0.58 6.52 ± 0.52
CON 5.76 ± 0.29 5.26 ± 0.26 7.04 ± 0.35 6.65 ± 0.37
Uric Acid-U µg/min * 0.229 0.025 0.994
REH 564.32 ± 86.24 775.35 ± 80.89
CON 445.87 ± 19.81 658.69 ± 68.15

Values are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. Pre. d-ROMS, derivatives of reactive oxygen metabolites; BAP, biological antioxidant potential; REH, rehydrate trial; CON, control trial.